Regarding the activation profile of follicular T cells, no differences were observed in the percentage of CD4+ follicular T cells expressing the early activation marker CD25 or the later activation marker HLA-DR between luminal A and luminal B cancer (p > 0.05) (Supplementary Figure S4). This evidence concerns the gene CD4 and cancer.